Hoth Therapeutics Inc

NASDAQ:HOTH

1.20

+0.02 (+1.31%)

7:58:26 PM EDT: $1.20 0.00 (0.38%)

Hoth Therapeutics Inc Stock, NASDAQ:HOTH

590 Madison Avenue, 21st floor, New York, New York 10020

United States of America

Phone: +1.646.756.2997

Number of Employees: 6

http://www.hoththerapeutics.com

Description

Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.